Literature DB >> 9149728

Aristolochia sp and chronic interstitial nephropathies in Indians.

J L Vanherweghem.   

Abstract

Entities:  

Mesh：

Year:  1997        PMID： 9149728     DOI： 10.1016/S0140-6736(05)63243-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

Review 1.  Aristolochic acid nephropathy: epidemiology, clinical presentation, and treatment.

Authors:  Randy L Luciano; Mark A Perazella
Journal:  Drug Saf       Date:  2015-01       Impact factor: 5.606

2.  An integrated system for identifying the hidden assassins in traditional medicines containing aristolochic acids.

Authors:  Lan Wu; Wei Sun; Bo Wang; Haiyu Zhao; Yaoli Li; Shaoqing Cai; Li Xiang; Yingjie Zhu; Hui Yao; Jingyuan Song; Yung-Chi Cheng; Shilin Chen
Journal:  Sci Rep       Date:  2015-08-13       Impact factor: 4.379

3.  Evaluating weight of evidence in the mystery of Balkan endemic nephropathy.

Authors:  Travis Bui-Klimke; Felicia Wu
Journal:  Risk Anal       Date:  2014-06-20       Impact factor: 4.000

4.  Association of non-allopathic drugs and dietary factors with chronic kidney disease: A matched case-control study in South India.

Authors:  Sujiv Akkilagunta; K C Premarajan; Sreejith Parameswaran; Sitanshu Sekhar Kar
Journal:  J Family Med Prim Care       Date:  2018 Nov-Dec

5.  Aristolochic acid causes albuminuria by promoting mitochondrial DNA damage and dysfunction in podocyte.

Authors:  Yang Zhou; Xueqin Bian; Li Fang; Weichun He; Chunsun Dai; Junwei Yang
Journal:  PLoS One       Date:  2013-12-13       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.